Integrins and cancer

Current Opinion in Cell Biology

Volumn 8, Issue 5, 1996, Pages 724-730

  Varner, Judith A ^a   Cheresh, David A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN;

APOPTOSIS; CANCER CELL; CANCER INVASION; CELL PROLIFERATION; GENE EXPRESSION; MELANOMA; METASTASIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 0030271574     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(96)80115-3     Document Type: Article

References (77)

1. Hynes RO: Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992, 69:11-25.
2. Cheresh D: Integrins: structure, function and biological properties. Adv Mol Cell Biol 1993, 6:225-252.
3. Ruoslahti E, Pierschbacher M: Arg-Gly-Asp: a versatile cell recognition sequence. Cell 1986, 44:517-518.
4. Guadagno TM, Ohtsubo M, Roberts JM, Assoian RK: A link between cyclin A expression and adhesion-dependent cell cycle proliferation. Science 1993, 262:1572-1575.
5. Varner JA, Emerson DA, Juliano RL: Integrin α5β3 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol Biol Cell 1995, 6:725-740. This paper present studies that characterize the molecular mechanisms behind the growth inhibitory properties of the integrin α5β1. Expression of the unligated integrin affects cellular proliferation by inhibiting immediate early gene transcription and inducing transcription of a growth inhibitory gene.
6. Dike LE, Farmer SR: Cell adhesion induces expression of growth-associated genes in suspension arrested fibroblasts. Proc Natl Acad Sci USA 1988, 85:6792-6796.
7. Juliano RL, Haskill S: Signal transduction from the extracellular matrix. J Cell Biol 1993, 120:577-585.
8. Meredith JE Jr, Fazeli B, Schwartz MA: The extracellular matrix as a cell survival factor. Mol Biol Cell 1993, 4:953-961.
9. Montgomery AMP, Reisfeld RA, Cheresh DA: Integrin αvβ3 rescues melanoma from apoptosis in a three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994, 91:8856-8860.
10. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA: Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogeneic blood vessels. Cell 1994, 79:1157-1164.
11. Boudreau N, Sympson CJ, Werb Z, Bissell M: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995 , 267:891-893. This paper demonstrates that antagonists of β1 integrins or overexpression of the matrix-degrading protease stromelysin induce apoptosis in mammary epithelial cells that have been previously shown to be dependent on the basement membrane for differentiation into glandular structures. Interleukin1β-converting enzyme (ICE) expression is induced in these circumstances and inhibitors of ICE inhibit apoptosis, suggesting that integrin ligation may transduce signals that suppress apoptosis by inhibiting ICE expression.
12. Werb Z, Tremble PM, Behrendtsen O, Crowley E, Damsky CH: Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 1989, 109:877-889.
13. Schwartz MA, Both G, Lechene C: Effect of cell spreading on cytoplasmic pH in normal and transformed fibroblasts. Proc Natl Acad Sci USA 1989, 86:4525-4529.
14. Schwartz MA, Cragoe EJ Jr, Lechene CP: pH regulation in spread and round cells. J Biol Chem 1990, 265:1327-1332.
15. Schwartz MA, Lechene C, Ingber DE: Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin α5β1, independent of cell shape. Proc Natl Acad Sci USA 1991 88:7849-7853.
16. + antiporter by platelet-derived growth factor. Proc Natl Acad Sci USA 1992, 89:6138-6141.
17. Schwartz MA: Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J Cell Biol 1992, 120:1003-1010.
18. Pelletier AJ, Bodary SC, Levinson AD: Signal transduction by the platelet integrin αllbβ3: induction of calcium oscillations required for protein-tyrosine phosphorylation and ligandinduced spreading of stably transfected cells. Mol Biol Cell 1992, 3:989-998.
19. Leavesley DI, Schwarte MA, Cheresh DA: Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 1993, 121:163-170.
20. McNamee HP, Ingber DE, Schwartz MA: Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown. J Cell Biol 1993, 121:673-678.
21. Kornberg U, Earp HS, Turner CE, Prockop C, Juliano RL: Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of β1 integrins. Proc Natl Acad Sci USA 1991, 88:8392-8395.
22. Guan JL, Shalloway D: Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 1992, 358:690-692.
23. Symington BE: Fibronectin receptor modulates cyclin dependent kinase activity. J Biol Chem 1993, 267:25744-25747.
24. Vuori K, Ruoslahti E: Activation of protein kinase C precedes α5β1 integrin-mediated cell spreading on fibronectin. J Cell Biol 1993, 268:21459-21462.
25. Morino N, Mimura T, Hamasaki K, Tobe K, Ueki K, Kikuchi K, Takehara K, Kadowaki T, Yazaki Y, Nojima Y: Matrix/integrin interaction activates the mitogen-activated protein kinases, p44erk-1 and p42erk-2. J Biol Chem 1995, 270:269-273. This paper is one of the first to show that integrin ligation by attachment to the extracellular matrix protein fibronectin or by cross-linking with antiintegrin-β1 antibodies induces activation of the MAPKs extracellular regulated kinase (ERK)1 and ERK2. Furthermore, the authors show that this process is dependent on the actin cytoskeleton, as cytochalasin D inhibits the process.
26. Schlaepfer DD, Hanks SK, Hunter T, Van der Geer P: Integrin mediated signal transduction linked to Ras pathway by Grb2 binding to focal adhesion kinase. Nature 1994, 372:786-790.
27. Chen Q, Kinch MS, Lin TH, Nurridge K, Juliano RL: Integrin mediated cell adhesion activates mitogen activated protein kinases. J Biol Chem 1994, 269:26602-26605.
28. Chen H-C, Guan J-L: Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3 kinase. Proc Natl Acad Sci USA 1994, 91:10148-10152.
29. Guinebault C, Payrastre B, Racaud-Sultan C, Mazarguil H, Breton M, Maunco G, Plantavid M, Chap H: Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interaction of p85a with actin filamaents and focal adhesion kinase. J Cell Biol 1995, 129:831-842.
30. Kapron-Bras C, Fitz-Gibbon L, Jeevaratnam P, Wilkins J, Dedhar S: Integrin clustering stimulates p21ras activation. J Biol Chem 1993, 268:20701 -20704.
31. Yebra M, Filardo E, Bayna E, Kawahara J, Cheresh D: Induction of carcinoma cell migration on vitronectin by NF-icB dependent gene expression. Mol Biol Cell 1995, 6:841-850.
32. Vaheri A, Ruoslahti E: Fibroblast surface antigen produced but not retained by virus-transformed human cells. J Exp Med 1975, 142:530-535.
33. Mautner V, Hynes RO: Surface distribution of LETS protein in relation to the cytoskeleton of normal and transformed cells. J Cell Biol 1977, 75:743-768.
34. Wagner D, Ivatt R, Destree A, Hynes R: Similarities and differences between fibronectins of normal and transformed hamster cells. J Biol Chem 1981, 25:11708-11715.
35. Plantefaber L, Hynes RO: Changes in integrin receptors on oncogenically transformed cells. Cell 1989, 56:281-290.
36. Hirst R, Horwitz AF, Buck C, Rohrschneider L: Phosphorylation of the fibronectin receptor complex in cells transformed by oncogenes that encode tyrosine kinases. Proc Natl Acad Sci USA 1986, 83:6470-6474.
37. Dedhar S, Argraves WS, Suzuki S, Ruoslahti E, Pierschbacher MD: Human osteosarcoma cells resistant to detachment by an Arg-Gly-Asp-containing peptide overproduce the fibronectin receptor. J Cell Biol 1987, 105:1175-1182.
38. Dedhar S, Mitchell MD, Pierschbacher MD: The osteoblast-like differentiation of a variant of MG-63 osteosarcoma cell line correlated with altered adhesive properties. Connect Tissue Res 1989, 20:49-61.
39. Symington BE: Fibronectin receptor overexpression and loss of transformed phenotype in a stable variant of the K562 cell line. Cell Regul 1990, 1:637-648.
40. Giancotti FG, Ruoslahti E: Elevated levels of the α5β1 receptor suppresses the transformed phenotype of Chinese hamster ovary cells. Cell 1990, 60:849-859.
41. Schreiner C, Fisher M, Hussein S, Juliano RL: Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res 1991,51:1738-1740.
42. Del Sal G, Ruaro ME, Philipson L, Schneider C: The growth arrest-specific gene, gas-1, is involved in growth suppression. Cell 1992, 70:595-607.
43. Del Sal G, Collavin L, Ruaro M, Edomi P, Saccone S, Valle GD, Schneider C: Structure, function, and chromosome mapping of the growth suppressing human homologue of the murine gas-1 gene. Proc Natl Acad Sci USA 1994, 91:1848-1852.
44. Zutter MM, Santoro SA, Staatz WD, Tsung YL: Re-expression of the α2β1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA 1995, 92:7411-7415. During the transition of cells from the normal to the neoplastic state, expression of the integrin α2β1 is diminished. This paper demonstrates that re-expression of the α2β1 integrin in breast carcinoma cells dominantly regulates breast carcinoma cell behavior, restoring a more normal, glandular phenotype to breast carcinoma cells and inhibiting tumor development.
45. Keely PJ, Fong AM, Zutter MM, Santoro SA: Alteration of collagen-dependent adhesion, motility and morphogenesis by the expression of antisense alpha 2 integrin in mRNA in mammary cells. J Cell Sci 1995, 108:595-607.
46. Meredith J, Takada Y, Fomaro M, Languino LR, Schwartz MA: Inhibition of cell cycle progression by the alternatively spliced integrin beta (1C). Science 1995, 269:1570-1572. This paper is a significant work that indicates that alternatively spliced integrins differing in cytoplasmic tail residues can impact cell behavior differentially. This is the first indication that a specific integrin cytoplasmic tail can dominantly regulate cell cycle progression.
47. Fomaro M, Zheng DQ, Languino LR: The novel structural motif Gin (795)-Gln (802) in the integrin beta 1C cytoplasmic domain regulates cell proliferation. J Biol Chem 1995, 270:24666-24669. This paper demonstrates that a small region of the β1 C integrin cytoplasmic tail is responsible for regulating the effects of β1C on cell cycle progression and cellular proliferation.
48. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M, Buck CA: Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res 1990, 50:6757-6764.
49. Danen E, Jansen F, Van Kraats A, Comelissen I, Ruiter D, Van Miujen G: αv integrins in human melanoma: gain of αvβ3 and loss of αvβ5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice. Int J Cancer 1995, 61:491-496.
50. Felding-Habermann B, Mueller BM, Romerdahl CA, Cheresh DA: Involvement of integrin αv gene expression in human melanoma. J Clin Invest 1992, 89:2018-2022.
51. Sanders LC, Felding-Habermann B, Mueller BM, Cheresh DA: Role of αv integrins and vitronectin in human melanoma cell growth. Cold Spring Harb Symp Quant Biol 1992, 58:233-240.
52. Mitjans F, Sander D, Adan J, Sutter A, Martinez JM, Jaggle CS, Moyano JM, Kreysch HG, Piulats J, Goodman SL: An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice. J Cell Sci 1995,108:3067-3078.
53. Bartolazzi A, Cerboni C, Nicotra MR, Mottolese M, Bigotti A, Natali PG: Transformation and tumor progression are frequently associated with expression of the alpha 3/beta 1 heterodimer in solid tumors. Int J Cancer 1994, 58:488-491.
54. Van Waes C, Carey TE: Overexpression of the A9 antigen α6β4 in head and neck cancer. Otolaryngol Clin North Am 1992, 25:1117-1139.
55. Liebert M, Wedemeyer G, Stein JA, Washington RW, Van Waes C, Carey T, Grossman HB: The monoclonal antibody BQ16 identifies the α6β4 integrin on bladder cancer. Hybridoma 1993, 12:67-80.
56. Costatini RM, Falcioni R, Battista P, Zupi G, Kennel S, Colasante A, Venture I, Cucio C, Sacci A: Integrin α6β4 expression in human lung cancer as monitored by specific monoclonal antibodies. Cancer Res 1990, 50:6107-6112.
57. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino M, Radeva G, Bell JC, Dedhar S: A novel, ankyrin repeat-containing serine/threonine protein kinase interacts with the β1 cytoplasmic domain. Nature 1995, 379:91-96. This paper describes a novel integrin-associated serine/threonine kinase that can induce anchorage-independent growth and that can directly phosphorylate the integrin β1 cytoplasmic tail in vitro. This kinase may play an essential role in integrin-mediated signal transduction that contributes to induction of cellular proliferation.
58. Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124:619-626.
59. Zhang Z, Vuori K, Reed JC, Ruoslahti E: The α5β1 integrin supports survival of cells on fibronectin and upregulates bcl-2 expression. Mol Biol Cell 1995, 6:841-850. This paper is the first to document a regulation of the apoptosis suppressor Bcl-2 by integrin ligation. These studies demonstrate that integrins contribute to cell survival by transducing a signal that leads to Bcl-2 expression and function.
60. Stromblad S, Becker J, Yebra M, Brooks P, Cheresh DA: Suppression of p53 activity and p21 WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J Clin Invest 1996, 98:426-433. This paper documents the molecular mechanism by which antagonists of integrin αvβ3 inhibit angiogenesis by promoting apoptosis of endothelial cells. These studies demonstrate a regulation of p53 activity and Bcl-2 expression by integrin ligation that is inhibited by αvβ3 antagonists.
61. Clarke AS, Lotz MM, Chao C, Mercuric AM: Activation of the p21 pathway of growth arrest and apoptosis by the beta (4) integrin cytoplasmic domain. J Biol Chem 1995, 270:22673-22676. This paper demonstrates that the integrin β4 subunit induces cell cycle arrest in colon carcinoma cells by inducing the expression of the cell cycle inhibitor p21 WAF1/QP1, and that the cytoplasmic tail of integrin β4 is required for this activity.
62. Chan BM, Chan C, Matsuura, N, Takada Y, Zetter BR, Hemler ME: In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 1992, 251:1600-1602.
63. Cheresh D: Human endothelial cells synthesize and express an Arg-Gly-Asp directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 1987, 84:6471-6475.
64. Leavesley Dl, Ferguson GD, Wayner EA, Cheresh DA: Requirement of integrin β3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol 1992, 117:1101-1107.
65. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR: Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment Cell 1993, 73:309-319.
66. Filardo EJ, Brooks PC, Deming SL, Cheresh DA: Requirement of the NPXY motif in the integrin β3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo. J Cell Biol 1995, 130:441-450.
67. Nip J, Shibata H, Loskutoff D, Cheresh D, Brodt P: Human melanoma cells derived from lymphatic metastases use integrin αvβ3 to adhere to lymph node vitronectin. J Clin Invest 1992, 90:1406-1413.
68. Klemke RL, Yebra M, Bayna EM, Cheresh DA: Receptor tyrosine kinase signaling required for integrin αvβ5 directed cell motility but not adhesion on vitronectin. J Cell Biol 1994, 127:859-866.
69. Brooks PC, Stromblad S, Sanders L, Von Schalscha T, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh D: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996, 85:683-693. This paper is the first documentation that integrins and matrix metalloproteinases directly interact to influence tumor and endothelial cell invasion processes. These studies demonstrate that activated matrix metalloproteinase 2 binds to integrin αvβ3, and that this interaction promotes cellular invasion and contributes to angiogenesis.
70. Riikonen T, Westermarck J, Koivisto L, Broberg A, Kahari VM, Heino, J. Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1 (I) gene expression. J Biol Chem 1995, 270:13548-13552.
71. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH: Cooperative signalling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 1995, 129:867-879.
72. Brooks PC, Clark RAF, Cheresh DA: Requirement of vascular integrin cxv3 for angiogenesis. Science 1994, 264:569-571.
73. Sepp NT, Li L-J, Lee KH, Brown EJ, Caughman SWW, Lawley TJ, Swerlick RA: Basic fibroblast growth factor increases expression of the αvβ3 complex on human microvessel endothelial cells. J Invest Dermatol 1994,103:295-299.
74. Enenstein J, Waleh NS, Kramer RH: Basic FGF and TGFβ differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 1992, 203:499-503.
75. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA: Definition of two angiogenic pathways by distinct αv integrins. Science 1995, 27:1500-1502.
76. Brooks P, Stromblad S, Klemke R, Visscher D, Sarkar F, Cheresh D: Antiintegrin αvβ3 blocks breast cancer growth and angiogenesis in human skin. J Clin Invest 1995, 96:1815-1822.
77. Drake CJ, Cheresh DA, Little CD: An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization. J Cell Sci 1995, 108:2655-2661.